Your SlideShare is downloading. ×
0
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
H ms cs_capabilities_competitive_analysis_ 7-11-12
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

H ms cs_capabilities_competitive_analysis_ 7-11-12

240

Published on

Presentation of Capabilities and Competitive Advantage of Neuromics' umbilical derived human stem cells and MSCGro high performance growth and differentiation media.

Presentation of Capabilities and Competitive Advantage of Neuromics' umbilical derived human stem cells and MSCGro high performance growth and differentiation media.

Published in: Technology, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
240
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Potent Human Mesenchymal Stem Cells and Media Capabilities and Competitive Analysis www.neuromics.com
  • 2. STEM CELL PRODUCTS Focus on Mesenchymal Stem Cells-Why MSCs?• Numerous Clinical Uses: Joint disease & injury, autoimmunity, stroke, organ failure (heart, liver, kidney & lung), MS, promotion of HSC engraftment, regenerative medicine, cancer, hearing loss, etc.• Readily Available: Blood, adipose (fat) tissue, bone marrow, teeth, etc
  • 3. GFP-Expressing Human MSCs Catalog Number SC00A4 Image: FITC of Single Human MSC GFP-Expressing Human MSCs express label in the cytoplasm.Illustrates morphological detail of human mesenchymal stem cells.
  • 4. GFP-Expressing Human MSCsFITC Image FITC + PC showing selection
  • 5. Red Fluorescent Human Mesenchymal Stem Cells Self-Renewal Transfer of label to chondrocyte (25 mM PGE2)
  • 6. MSC Growth in Low Serum MSCGro™ Compared to Lonza MSC-GM MSCGroTM at Day 3 MSCGroTM at Day 4 Lonza at Day 3 Lonza at Day 4
  • 7. Human MSC Growth in MSCGroTM vs Competitors Media:MSCGroTM results in faster growth & 2-3-fold greater cell recovery
  • 8. 160 Real Time Stability of MSCGro 140 Compared to Competitors Medium 120Doubling Time (Hrs) 100 MSCGro at 5% O2 MSCM-ScienCell at 5% O2 80 MSCGro at 20% O2 60 (Adipose MSCs by third party) 40 20 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 o Months at 2-8 C
  • 9. Humanized Complete & Humanized Powder MSCGro™
  • 10. Differentiation of Human MSCs Cultured in MSC-GroTM MediumChondrocyte Stained Adipocytes Stained with Osteoblast Stained with Alcian Blue Oil Red with Alizarin Red
  • 11. Competitive Advantages of MSCGroTM• MSC growth rate/cell recovery > Lonza, InVitrogen, Stem Cell Technologies, ScienCell & ZenBio media.• MSC quality/potency (Lumenesc™) > Lonza, InVitrogen and Stem Cell Technologies media.• Vastly improved real time stability.• Medium function unaffected by freezing.• Out-performs competitors at both reduced & ambient O2• Supports self-renewal of human, rat & mouse MSCs• Also supports primary cultures: fibroblasts (human & rat); rat cardiomyocytes & possibly hepatocytes• Provided complete & ready to use as is.

×